Search results
Interim results of IGNAZ trial sheds positive light on felzartamab for IgAN
Clinical Trials Arena via Yahoo Finance· 5 days agoAt this year’s European Renal Association Congress, positive interim results were presented from...
Cell therapy reckoning: How a 'remarkable resolution of lupus' carried CAR-T from cancer to ...
FierceBiotech· 4 days agoThis story is part 3 in a four-part series about cell therapy created by the Fierce Biotech team....
Nociceptor-immune interactomes reveal insult-specific immune signatures of pain - Nature Immunology
Nature· 7 days agoWoolf and colleagues use single-cell transcriptomics to determine the gene signature of infiltrating immune cells and potential cell–cell interactions between receptors, ligands, ion channels ...
Q&A: Researchers determine that a subclass of stem cells replenish platelets more rapidly
Medical Xpress· 6 hours agoMazzi: Platelets, the blood cells critical for preventing and stopping bleeding, are short-lived and in need of constant replenishment by blood-forming stem cells residing in the bone marrow ...
NIH Says Existing Drug Shows Promise as Treatment for Rare Genetic Disorder of Autoimmune...
Sierra Sun Times· 7 hours agoNIH researchers find new pathways towards treatment for autoimmune polyendocrine syndrome type 1....
Joanina Gicobi's road from rural Kenya to earning her Ph.D. in Rochester came through resilience,...
Post-Bulletin· 6 days agoIt's this resilience — and the support of others who saw Gicobi's potential — that resulted in Gicobi coming to the U.S. for college and earning her Ph.D. in immunology at ...
Glaxo (GSK) Up 1.6% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 3 days agoExcluding Xevudy sales, revenues in the Specialty Medicines segment were up 19%. Sales grew in HIV, ...
AbbVie (ABBV) Soars 3.2%: Is Further Upside Left in the Stock?
Zacks via Yahoo Finance· 15 hours agoAbbVie (ABBV) saw its shares surge in the last session with trading volume being higher than...
Intellia’s CRISPR drug shows promise against hereditary angioedema in early-stage trial - Boston...
The Business Journals· 1 day agoThe Cambridge genome editing company shared new data at the European Academy of Allergy and Clinical...
Affinity gaps among B cells in germinal centers drive the selection of MPER precursors - Nature ...
Nature· 5 days agoBatista, Schief and colleagues use a series of germline-targeting immunogens in knock-in mice expressing heavy chain sequences derived from the HIV broadly neutralizing antibody 10E8 to characterize ...